Friday, January 4, 2013

Flu Vaccine Mandates and Talking Points funded by Pharma, naturally

I did not have to look far to find the source of that meaningless little factoid used by the Goshen hospital spokesperson and the British Columbia chief medical officer: 
"Influenza is the most frequent cause of death from a vaccine-preventable disease in the United States."  

It was the very first sentence in a flu vaccine "resource" for health professionals on the Immunization Action Coalition website.  Guess all you need is to read a sentence or two and then you have enough ammunition to fire your employees.



The IAC has created an "Honor Roll" of institutions that force flu vaccine on their employees and make their lives miserable if they don't comply:


Honor Roll for Patient Safety

Mandatory Influenza Vaccination for Healthcare Workers

IAC is recognizing the stellar examples of influenza vaccination mandates in healthcare settings. The best way to prevent transmission of influenza to our patients is to mandate vaccination of healthcare workers. The Honor Roll represents the champions who have taken the lead in mandating influenza vaccination within their organization or institution. To be included in the honor roll, your organization's mandate must require influenza vaccination for employees and must include serious measures to prevent transmission of influenza from unvaccinated workers to patients. Such measures might include a mask requirement, reassignment to non-patient-care duties, or dismissal of the employee.

The list of who pays for this includes:


National Center for Immunization and Respiratory Diseases, CDC
Foundations
Mark and Muriel Wexler Foundation
Anonymous
Pharmaceutical Companies
Baxter Healthcare Corp.
CSL Biotherapies
GlaxoSmithKline
MedImmune, Inc.
Merck Sharp & Dohme Corp.
Novartis Vaccines
Ortho Clinical Diagnostics, Inc.
Pfizer Inc.
sanofi pasteur
Professional Societies
American Pharmacists Association
Individuals and Others
Combined Federal Campaign donors
Health plans
Hospitals

No comments: